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Abstract
Background—The relationship between coronary endothelial function and coronary calcification
is not well established.
Methods—Forty-six patients (17 men [37%]; age, 47.4±11.4 years prospectively underwent testing
for coronary endothelial function and measurement of coronary artery calcification (CAC).
Results—Log CAC scores were not significantly different between patients with normal (n=31)
and abnormal (n=15) response of epicardial coronary artery diameter to acetylcholine (%CADAch)
(median (25, 75 percentile) (1.1 (0.0, 3.7) vs 0.3 (0.0, 2.4), P=.32) and with normal (n=28) and
abnormal (n=18) response of coronary blood flow to acetylcholine (%CBFAch) (0.5 (0.0, 3.6) vs 0.5
(0.0, 3.2), P=.76). Log CAC scores did not correlate with %CADAch (r=0.08, P=.59), %CBFAch
(r=0.14, P=.35).
Conclusions—In patients without significant coronary artery disease, coronary endothelial
dysfunction showed no apparent association with coronary calcification. Our findings suggest that
these 2 markers may represent separate, independent processes in the progression of coronary
atherosclerosis.
Keywords
coronary calcification; early coronary atherosclerosis; electron beam computed tomography;
endothelial dysfunction
Introduction
Among the markers of subclinical atherosclerosis that have proved predictive of future cardiac
events are coronary endothelial dysfunction and coronary artery calcification (CAC) [1.2].
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These are attractive measures in that they both directly examine the vascular bed at risk and
do not rely on concordance between coronary artery disease and non-coronary atherosclerosis.
Functional abnormalities could be expected to precede structural abnormalities in the
pathogenesis of atherosclerosis; for example, previous studies could not identify a relationship
between coronary plaque on intravascular ultrasound and coronary endothelial dysfunction
[3]. A noninvasive, inexpensive technique such as cardiac CT might be preferable over an
invasive, expensive procedure such as cardiac catheterization for the assessment of
cardiovascular risk if both tests provided concordant information.
Hence, the goal of our study was to explore the relationship between coronary endothelial
dysfunction and CAC.
Methods
Patients
We prospectively enrolled patients referred by independent physicians for the assessment of
coronary endothelial function. Patients had recurrent chest pain and/or positive cardiac stress
testing and negative findings thorough evaluation of lungs and gastrointestinal tract. Patients
with early atherosclerosis (coronary artery luminal narrowing <30%) were underwent coronary
endothelial function test and the procedure for CAC scanning within 2 weeks of the coronary
catheterization procedure. Exclusion criteria were described previously [4]. The Mayo Clinic
Institutional Review Board approved the study, and informed consent was obtained from all
participants.
Endothelial Function Assessment and Coronary Flow Reserve
Coronary angiography was performed in standard technique [4]. Coronary endothelial function
of the LAD was assessed as previously described [4]. To evaluate endothelium-independent,
microvascular coronary flow reserve (CFR), intracoronary bolus injections of adenosine
(Fujisawa Healthcare Inc., Deerfield, IL) were administered and CFR was calculated [4].
To assess endothelium-dependent function, acetylcholine (Iolab Pharmaceuticals, Claremont,
CA) was selectively infused into the LAD for 3 minutes at increasing concentrations (10−6,
10−5, and 10−4 mol/L) respectively. Coronary artery diameter and average peak velocity were
measured and coronary blood flow was calculated from the Doppler-derived time velocity
integral and vessel diameter [4].
The percent change of coronary artery diameter in response to acetylcholine (%CADAch) was
measured in the mid LAD 5 mm distal to the tip of the Doppler wire after each infusion. The
degree of endothelial function in the coronary microcirculation was defined by the percent
change of coronary blood flow in response to acetylcholine (%CBFAch). The %CBFAch was
calculated by dividing the coronary blood flow after infusing acetylcholine (concentration,
10−4 M; 18.2 μg/mL) by the blood flow at baseline.
Definitions of Abnormal Endothelial Function
Abnormal coronary epicardial endothelial function was defined as a decrease in %ΔCADAch
by >20% [4]. Abnormal endothelium-dependent function in the coronary microcirculation was
defined as %ΔCBFAch by <50%, or a ratio between measurements before and after
acetylcholine <1.5. Impaired endothelium-independent function of the coronary
microcirculation was defined as a CFR of 2.5 or lower [4].
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Electron Beam Computed Tomography
The procedure for CAC scanning with electron beam CT (Imatron; GE Healthcare, Milwaukee,
WI) was performed as previously described [5]. Forty to 60 tomograms were acquired to cover
the entire heart in all patients. The field of view was 26 cm with a 512 × 512 pixel matrix
(resolution, 0.51 × 0.51 mm/pixel). Presence of CAC on EBCT tomograms was defined as 2
or more contiguous pixels with a brightness of at least 130 Hounsfield units. Regions of interest
surrounding areas of CAC were traced by trained technicians using custom software. CAC
scores were calculated following previously described methods [6] for the entire coronary tree
(total) and for the LAD only. CAC scores were not normally distributed, log CAC scores were
used for statistical analysis.
Statistical Analysis
Continuous variables were presented as mean±SD or as median (interquartile range). Discrete
data were presented as frequencies and percentages. Associations between 2 continuous
variables were measured with the Spearman rank correlation test. Associations between 2
discrete variables were tested using the Pearson χ2 test. Group differences in continuous
measures were made by Mann-Whitney U-test. All hypothesis tests were 2-tailed with a
significance level of 0.05.
Results
Study Patients
Forty-six patients (17 men [37%]; age, 47±11 years) were prospectively enrolled in the study.
Analysis by Presence or Absence of Coronary Artery Calcium
Patients with detectable CAC (n=26) were significantly older (P=.04) and had a higher body
mass index (P=.02) and fasting glucose level (P=.02). Other baseline characteristics, in
particular the serum lipids profiles, were not different between groups. No significant
differences between groups were present for %ΔCADAch, %ΔCBFAch, CFR (Supplementary
data Table 2).
Analysis by Presence or Absence of Abnormal Coronary Physiology
Total log CAC scores and log CAC scores of LAD were not different between groups by the
results of endothelial function and CFR (Table 1).
Correlation Between Coronary Endothelial Dysfunction and Coronary Calcification
Total log CAC scores was not significantly correlated with %ΔCADAch (r=0.08, P=.59), %
ΔCBFAch (r=0.14, P=.35), CFR (r=0.15, P=.32) (Fig 1). Similarly, log CAC scores of LAD
also was not significantly correlated with these parameters (0.05≤r≤0.14, all P=NS). Of
interest, even after adjusting for age, body mass index, fasting glucose level, and mean arterial
pressure, total log CAC scores was not significantly correlated with %ΔCADAch (r=0.006,
P=.97), %ΔCBFAch (r=0.24, P=.19), CFR (r=0.27, P=.12). This lack of correlation does not
appear to be related to skewing of the data by the many subjects who had no CAC. Among the
26 patients with detectable CAC, no significant association was identified between these
measures of coronary endothelial function (%ΔCADAch, %ΔCBFAch, CFR) and total log CAC
scores (−0.17<r<0.39, all P=NS) or log CAC scores of LAD (−0.003<r<0.24, all P=NS).
Discussion
Previous studies of the relationship between endothelial function in various vascular beds
assessed noninvasively and CAC have shown conflicting results [7,8]. We, for the first time,
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demonstrated that, in patients with chest pain in the absence of significant CAD, there is no
appreciable relationship between CAC scores and quantitative or qualitative measures of
coronary endothelium-dependent or independent function.
The lack of correlation between coronary endothelial function and CAC in our study may have
several explanations. First, these two markers may well represent separate processes in the
development of coronary atherosclerosis. Previous experimental studies suggest that
osteopontin-mediated vascular calcification may originate from an osteoprogenitor cell
population in the adventitia [9] and occur independently of atheroma formation associated with
endothelial injury.
Second, CAC may represent structural changes of the endothelium, media, and adventitia that
reflect mechanisms of atherosclerosis progression unrelated to endothelial function, such as
plaque rupture, or intraplaque hemorrhage associated with immature neovascularization [10].
Studies that examined CAC patterns with intravascular ultrasound or CT showed that the culprit
coronary lesions in patients with acute coronary syndromes had less or spotty calcification
when compared with stable plaques in other vessels, and also are less likely to be calcified than
the plaques of patients with chronic stable angina [11]. Importantly, CAC is usually not present
in the earliest fatty streak atherosclerotic lesions and adverse cardiac events may occur in the
absence of CAC [2]. A recent in vitro study [12] showed that CAC quantity assessed by CT
was not related to morphologic predictors of likelihood of rupture such as intraplaque
hemorrhage, lipid content, inflammation, or plaque size.
Third, the relationship between markers of subclinical inflammation and CAC is tenuous [7].
This lack of a relationship between inflammation and CAC is yet another likely partial
explanation of our findings.
The main limitations of coronary endothelial function assessment as a measure of early
atherosclerosis are its invasive nature and the fact that it assesses the functional interaction
between the endothelium and the media but cannot address the atherosclerotic process at the
level of the adventitia. However, the clinical importance of detecting coronary endothelial
dysfunction is suggested by a previous study which demonstrated that the treatment of
endothelial function can reduce the incidence of cardiac events [13]. Conversely, although high
quantities of CAC can be present without evidence for advanced CAD in the form of myocardial
perfusion abnormalities on Tc-99m single-photon emission CT [14], randomized, prospective
studies to date have not shown an effect of risk factor modification on the progression of CAC
or on clinical outcomes [15].
The considerations on the pathophysiology of atherosclerosis discussed above suggest that
endothelial dysfunction and CAC may represent two distinct and separate processes in the
development of coronary atherosclerosis at least at the early stage, and may provide
complementary information in the assessment of subclinical coronary artery disease.
The main limitations of our study are the small number of study patients and the likely presence
of referral bias. Further study for this topic in patients with higher CAC and early
atherosclerosis or in patients with coronary artery disease are needed in the future.
Conclusions
Our results support the concept that coronary endothelial dysfunction and CAC may be separate
phenomena in the development of atherosclerosis, especially at the early stage. These two
phenomena may contribute differently to plaque biology and provide complementary
information on future risk of cardiac events.
Han et al. Page 4
Atherosclerosis. Author manuscript; available in PMC 2011 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Abbreviations
CAC coronary artery calcification
%CADAch percent change of coronary artery diameter in response to acetylcholine
%CBFAch percent change of coronary blood flow in response to acetylcholine
CFR coronary flow reserve
CT computed tomography
LAD left anterior descending coronary artery
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Figure 1.
A, B There was no significant correlation between %CADAch and total log CAC scores (A)
and %CBFAch and total log CAC scores (B) in the overall study group.
%CADAch, percent change of coronary artery diameter in response to acetylcholine, %
CBFAch, percent change of coronary blood flow in response to acetylcholine, CAC, coronary
artery calcification
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